Valuation : Ginwa Enterprise (Group) Inc.

Market Cap 1.74B 258M 222M 208M 190M 358M 24.65B 359M 2.47B 965M 12.44B 968M 947M 41.26B P/E 2024
37.4x
P/E 2025 171x
Enterprise Value 1.38B 205M 177M 166M 151M 285M 19.62B 286M 1.97B 768M 9.91B 771M 754M 32.84B EV / Sales 2024
4.15x
EV / Sales 2025 4.24x
Free-Float
66.46%
Yield 2024
0.38%
Yield 2025 0.4%
1 day+0.61%
1 week+2.71%
Current month+1.86%
1 month+2.07%
3 months-10.55%
6 months-46.29%
Current year-34.75%
1 week 4.66
Extreme 4.66
4.98
1 month 4.61
Extreme 4.61
5.01
Current year 4.26
Extreme 4.26
9.3
1 year 4.26
Extreme 4.26
9.35
3 years 4.26
Extreme 4.26
9.35
5 years 4.26
Extreme 4.26
10.97
10 years 3.7
Extreme 3.7
14.93
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-28
Director of Finance/CFO 44 2025-04-09
Corporate Officer/Principal 30 2022-02-15
Director TitleAgeSince
Director/Board Member 63 2011-04-20
Chairman 55 2020-06-28
Chairman 59 2022-02-21
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+2.71%-34.14%-31.09% 258M
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.62%-1.92%+22.22%+40.05% 365.95B
Weighted average by Cap. -0.46%-3.46%+38.17%+65.00%

Financials

2024 2025
Net sales 585M 87.02M 74.98M 70.3M 64.18M 121M 8.32B 121M 834M 325M 4.2B 327M 320M 13.92B 544M 80.86M 69.68M 65.33M 59.64M 112M 7.73B 113M 775M 302M 3.9B 304M 297M 12.94B
Net income 74.61M 11.09M 9.56M 8.96M 8.18M 15.41M 1.06B 15.46M 106M 41.47M 535M 41.64M 40.73M 1.77B 15.58M 2.32M 1.99M 1.87M 1.71M 3.22M 221M 3.23M 22.19M 8.66M 112M 8.69M 8.5M 370M
Net Debt -327M -48.53M -41.82M -39.21M -35.79M -67.43M -4.64B -67.64M -465M -181M -2.34B -182M -178M -7.76B -354M -52.61M -45.33M -42.51M -38.8M -73.1M -5.03B -73.33M -504M -197M -2.54B -198M -193M -8.42B
Logo Ginwa Enterprise (Group) Inc.
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Employees
613
Date Price Change Volume
26-08-28 CN¥4.920 +0.61% 2,844,400
26-08-27 CN¥4.890 +0.62% 3,393,000
26-08-26 CN¥4.860 +0.83% 2,395,800
26-08-25 CN¥4.820 +2.77% 2,479,500
26-08-24 CN¥4.690 -2.09% 1,788,800
  1. Stock Market
  2. Stocks
  3. 600080 Stock